Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients.

Matthieu GiotToscane FouriéGuillaume LanoPaola Mariela Saba VillarroelXavier de LamballeriMarion GullyLaurent SamsonJulien FaraultDammar BouchouarebOcéane JehelPhilippe BrunetNoémie Jourde-ChicheLaetitia NinoveThomas Robert

Published in: Clinical kidney journal (2021)

Most HD patients develop a substantial humoral response against SARS-CoV2, with Nabs, following the mRNA vaccine. Whether this immunity persists over time and is able to efficiently protect patients from coronavirus disease 2019 remains to be determined.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
newly diagnosed
peritoneal dialysis
prognostic factors
respiratory syndrome coronavirus
zika virus